Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenC-TT and Hib-MenC-TT Vaccines in Infants
NCT00135486Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2002
- Primary completion
- Jan 2003
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of meningococcal group c polysaccharide-tetanus toxoid conjugate vaccine, Hib-MenC-TT in meningococcal infection, Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Mar 2002; status: completed.
02
Drugs
meningococcal group c polysaccharide-tetanus toxoid conjugate vaccineHib-MenC-TT
03
Conditions
meningococcal infectionHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00135486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135486.